Acorda Therapeutics, Inc. (ACCD.US) stock price is influenced by several factors: Clinical Trial Results: Positive or negative data from Acorda's clinical trials for new or existing drugs can significantly impact investor sentiment. Regulatory Decisions: FDA approvals, rejections, or delays for Acorda's drug candidates directly affect future revenue potential. Financial Performance: The company's revenue, profitability, cash flow, and debt levels influence investor confidence. Competition: The emergence of competing drugs or therapies in Acorda's target markets can reduce market share and revenue. Market Conditions: Broader market trends, economic conditions, and overall investor sentiment towards the biotech sector can impact ACCD. Partnerships/Acquisitions: Any strategic alliances, collaborations, or potential acquisitions involving Acorda can affect its stock price. Management Changes: Changes in leadership or key personnel can sometimes impact investor perception of the company's direction. Patent Protection: The strength and duration of Acorda's patent portfolio for its products are crucial for maintaining market exclusivity. Disease Prevalence: Changes in the prevalence or diagnosis rates of the diseases Acorda's drugs treat can affect demand.